G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 2 029.8 INR 1% Market Closed
Market Cap: 572.8B INR

Intrinsic Value

The intrinsic value of one GLENMARK stock under the Base Case scenario is hidden INR. Compared to the current market price of 2 029.8 INR, Glenmark Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLENMARK Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Glenmark Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

GLENMARK looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether GLENMARK usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about GLENMARK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GLENMARK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Glenmark Pharmaceuticals Ltd.

Explain Valuation
Compare GLENMARK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLENMARK?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Glenmark Pharmaceuticals Ltd

Current Assets 114.5B
Cash & Short-Term Investments 29.1B
Receivables 37.7B
Other Current Assets 47.7B
Non-Current Assets 75.5B
Long-Term Investments 1.2B
PP&E 40.9B
Intangibles 18.1B
Other Non-Current Assets 15.3B
Current Liabilities 69.6B
Accounts Payable 29.5B
Other Current Liabilities 40.1B
Non-Current Liabilities 24.6B
Long-Term Debt 7.8B
Other Non-Current Liabilities 16.8B
Efficiency

Free Cash Flow Analysis
Glenmark Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Glenmark Pharmaceuticals Ltd

Revenue
159.6B INR
Cost of Revenue
-44.5B INR
Gross Profit
115B INR
Operating Expenses
-79.2B INR
Operating Income
35.8B INR
Other Expenses
-25.7B INR
Net Income
10.1B INR
Fundamental Scores

GLENMARK Profitability Score
Profitability Due Diligence

Glenmark Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Positive ROIC
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Glenmark Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

GLENMARK Solvency Score
Solvency Due Diligence

Glenmark Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

hidden
Solvency
Score

Glenmark Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd

Wall Street analysts forecast GLENMARK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLENMARK is 2 187.72 INR with a low forecast of 1 515.41 INR and a high forecast of 2 871.75 INR.

Lowest
Price Target
1 515.41 INR
25% Downside
Average
Price Target
2 187.72 INR
8% Upside
Highest
Price Target
2 871.75 INR
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLENMARK is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GLENMARK stock?

The intrinsic value of one GLENMARK stock under the Base Case scenario is hidden INR.

Is GLENMARK stock undervalued or overvalued?

Compared to the current market price of 2 029.8 INR, Glenmark Pharmaceuticals Ltd is hidden .

Back to Top